Nerve fibre loss and an increase in key immune cells on the cornea may be an identifying feature of ‘long COVID’, suggests a small study published in the British Journal of Ophthalmology. Read more
Nanodrug macular treatment yields ‘impressive results’
A leading researcher in Queensland has lauded the efficacy of a pioneering treatment for ocular neovascular disease recently trialled in animals.
NovaTears + Omega-3 effective against evaporative dry eye – study
Australasian drug company AFT Pharmaceuticals has announced results from a post-market study of licensed dry eye therapy NovaTears + Omega-3, stating it is a significantly effective treatment for the evaporative form of the disease. Read more
Clinic with optomap imaging cuts visits by a third
A study conducted at a prominent research university has found patient visits were 28 minutes shorter on average after systemic changes to its workflow, including the implementation of decentralised optomap imaging. Read more
Infrared light could replace injections for macular oedema
A clinical trial at Sydney Eye Hospital is evaluating the safety and efficacy of using infrared light to treat macular oedema from retinal vein occlusions, instead of the current standard treatment of eye injections. Read more
Survey to paint a clearer picture on eyecare nurse workforce
Australia’s nurses are at the centre of a survey that will create a snapshot of the eyecare nurse workforce and shape discussion about their future involvement in the sector. Read more
Clinical trials imminent for glaucoma genetic test
Australian researchers have led the development of a promising new genetic test for glaucoma that can potentially identify 15-times more people at high risk of glaucoma than an existing genetic test. Read more
New tech ‘will change night vision landscape forever’
New infrared night vision technology that is extremely lightweight, cheap and easy to mass produce could be applied to standard glasses and make it safer to drive at night, Australian researchers claim. Read more
New paper sheds light on myopia control axial length targets
A new paper comparing axial elongation differences among untreated myopes, myopes fitted with a control contact lens and emmetropes has helped further the understanding of myopia control efficacy in the context of normal childhood eye growth. Read more
Inaugural macular disease study offers fresh insight into patient experiences
The Macular Disease Foundation Australia (MDFA)’s first-ever social impact survey has revealed a quarter of patients have low levels of knowledge of their condition, with roughly the same proportion less than happy with the explanation of their disease by their eyecare professional.